UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer

Journal of clinical oncology, 2021-02, Vol.39 (6), p.557-564

2021

Link zum Volltext

Verfügbarkeit prüfen

Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean

Statistics in medicine, 2010-01, Vol.29 (1), p.33-45

Crager, Michael R.

2010

Link zum Volltext

Verfügbarkeit prüfen

Extensions of the absolute standardized hazard ratio and connections with measures of explained variation and variable importance

Lifetime data analysis, 2020-10, Vol.26 (4), p.872-892

Crager, Michael R.

2020

Link zum Volltext

Verfügbarkeit prüfen

Reply to K. Ando et al

Journal of clinical oncology, 2021-06, Vol.39 (17), p.JCO2100424-1948

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety of a novel antianginal agent in patients with severe chronic stable angina : The Ranolazine Open Label Experience (ROLE)

Journal of the American College of Cardiology, 2007-03, Vol.49 (10), p.1027-1034

2007

Link zum Volltext

Verfügbarkeit prüfen

Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy

Urologic oncology, 2022-03, Vol.40 (3), p.104.e1-104.e7

2022

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score

Urology (Ridgewood, N.J.), 2016-03, Vol.89, p.69-75

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective Calculation of Identification Power for Individual Genes in Analyses Controlling the False Discovery Rate

Genetic epidemiology, 2012-12, Vol.36 (8), p.839-847

Crager, Michael R.

2012

Link zum Volltext

Verfügbarkeit prüfen

GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific Mortality

JCO precision oncology, 2021, Vol.5

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin

Journal of gastrointestinal oncology, 2022-02, Vol.13 (1), p.126-136

2022

Link zum Volltext

Verfügbarkeit prüfen

Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer

Contemporary clinical trials, 2017-12, Vol.63, p.30-39

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression

Journal of applied statistics, 2014-01, Vol.41 (12), p.2676-2695

2014

Link zum Volltext

Verfügbarkeit prüfen

Generalizing the standardized hazard ratio to multivariate proportional hazards regression, with an application to clinical~genomic studies

Journal of applied statistics, 2012-02, Vol.39 (2), p.399-417

Crager, Michael R.

2012

Link zum Volltext

Verfügbarkeit prüfen

Separate Class True Discovery Rate Degree of Association Sets for Biomarker Identification

Journal of biopharmaceutical statistics, 2014-01, Vol.24 (5), p.1022-1034

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract GS4-10: Development and validation of a tool integrating the 21-gene recurrence score and clinicopathlogic features to individualize prognosis for distant recurrence and prediction of absolute chemotherapy benefit in early breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.GS4-10-GS4-10

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina

Journal of the American College of Cardiology, 2007-03, Vol.49 (10), p.1027-1034

2007

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD15-05-PD15-05

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Covariance in Parallel-Group Clinical Trials with Pretreatment Baselines

Biometrics, 1987-12, Vol.43 (4), p.895-901

Crager, Michael R.

1987

Link zum Volltext

Verfügbarkeit prüfen

Running Average Analysis of Clinical Trial Ambulatory Blood Pressure Data

Biometrics, 1991-03, Vol.47 (1), p.129-137

1991

Link zum Volltext

Verfügbarkeit prüfen

Met-enkephalin, age and anatomy: A microiontophoretic study in the hippocampus

Life sciences (1973), 1987-01, Vol.40 (2), p.203-213

1987

Link zum Volltext

Verfügbarkeit prüfen

Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water

Clinical infectious diseases, 2012-11, Vol.55 (9), p.e79-e85

2012

Link zum Volltext

Verfügbarkeit prüfen

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer

Breast cancer research : BCR, 2022-11, Vol.24 (1), p.74-74, Article 74

2022

Link zum Volltext

Verfügbarkeit prüfen

Correlation of the oncotype DX breast recurrence score and the ki-67 IHC MIB-1 pharmDX score in HR+, HER2-, node-positive early breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12556-e12556

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes

European heart journal, 2006-01, Vol.27 (1), p.42-48

2006

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific meta-analysis (MA) of two validation studies to predict pathologic outcomes in prostate cancer (PCa) using a 17-gene genomic prostate score (GPS)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.100-100

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(15)
Humans
(14)
Female
(9)
Male
(8)
Mathematics
(7)
Physical Sciences
(7)
Statistics & Probability
(7)
Aged
(6)
Middle Aged
(6)
Biological And Medical Sciences
(5)
Oncology
(5)
Mathematical & Computational Biology
(4)
Prognosis
(4)
Treatment Outcome
(4)
Adult
(3)
Angina Pectoris - Drug Therapy
(3)
Breast Neoplasms - Genetics
(3)
Chronic Disease
(3)
Estimates
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer

Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean

Extensions of the absolute standardized hazard ratio and connections with measures of explained variation and variable importance

Reply to K. Ando et al

Long-term safety of a novel antianginal agent in patients with severe chronic stable angina : The Ranolazine Open Label Experience (ROLE)

Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy

Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score

Prospective Calculation of Identification Power for Individual Genes in Analyses Controlling the False Discovery Rate

GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific Mortality

Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin

Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer

Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression

Generalizing the standardized hazard ratio to multivariate proportional hazards regression, with an application to clinical~genomic studies

Separate Class True Discovery Rate Degree of Association Sets for Biomarker Identification

Abstract GS4-10: Development and validation of a tool integrating the 21-gene recurrence score and clinicopathlogic features to individualize prognosis for distant recurrence and prediction of absolute chemotherapy benefit in early breast cancer

Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina

Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42

Analysis of Covariance in Parallel-Group Clinical Trials with Pretreatment Baselines

Running Average Analysis of Clinical Trial Ambulatory Blood Pressure Data

Met-enkephalin, age and anatomy: A microiontophoretic study in the hippocampus

Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer

Correlation of the oncotype DX breast recurrence score and the ki-67 IHC MIB-1 pharmDX score in HR+, HER2-, node-positive early breast cancer

Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes

Patient-specific meta-analysis (MA) of two validation studies to predict pathologic outcomes in prostate cancer (PCa) using a 17-gene genomic prostate score (GPS)

Suchergebnisse filtern